The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.875
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.25 (9.091%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.875
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Tue, 01st Dec 2020 16:06

Wednesday 2 December 
Kingswood Holdings LtdAGM
Target Healthcare REIT PLCAGM
JPMorgan Global Emerging Markets Income Trust PLCAGM
Gunsynd PLCGM re share placing
Rambler Metals & Mining PLCAGM
Thursday 3 December 
Nanoco Group PLCAGM
Marwyn Value Investors LtdAGM adjourned from 17 November
CQS New City High Yield Fund LtdAGM
B&M European Value Retail SAEGM re changes related to Brexit
MJ Gleeson PLCAGM
Ormonde Mining PLCAGM
Ferguson PLCAGM
Ceiba Investments LtdEGM re issue of shares at 104.3p each
STV Group PLCGM re bonus issue
Friday 4 December 
VinaCapital Vietnam Opportunity Fund LtdAGM
Auctus Growth PLCGM re purchase of HeiQ Materials AG
KKV Secured Loan Fund LtdEGM re investment policy, cash return, wind-down
Associated British Foods PLCAGM
Abcam PLCAGM
Hammerson PLCGM re scrip dividend
Warehouse REIT PLCGM re Greenstone acquisition
Monday 7 December 
Gore Street Energy Storage Fund PLCGM re placing programme
Renalytix AI PLCAGM
Inspecs Group PLCGM re share placing
Gabelli Value Plus+ Trust PLCGM re continuation resolution
McCarthy & Stone PLCGM re acquisition by Bidco
Tuesday 8 December 
Worsley Investors LtdAGM
Gattaca PLCAGM
Volta Finance LtdAGM
Allergy Therapeutics PLCAGM
Greatland Gold PLCAGM
Haydale Graphene Industries PLCAGM
Henderson International Income Trust PLCAGM
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Aug 2021 13:43

Allergy Therapeutics upbeat on ex-vivo study of peanut allergy vaccine

(Sharecast News) - Pharmaceutical biotechnology company Allergy Therapeutics announced positive primary results from an ex-vivo biomarker study on Tuesday, evaluating its novel virus-like particle (VLP)-based peanut allergy vaccine candidate, VLP Peanut.

Read more
14 Jul 2021 12:29

Allergy Therapeutics expects revenue rise in year despite challenges

Allergy Therapeutics expects revenue rise in year despite challenges

Read more
24 Jun 2021 19:56

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

Read more
24 Jun 2021 08:07

Allergy Therapeutics FY profits seen 'well ahead' of expectations

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said on Thursday that full-year operating profits were expected to be "well ahead" of market expectations thanks to "significantly lower" expenses.

Read more
6 May 2021 19:25

TRADING UPDATES: Superdry optimistic; Virgin Wines toasts demand surge

TRADING UPDATES: Superdry optimistic; Virgin Wines toasts demand surge

Read more
6 May 2021 15:34

Allergy Therapeutics completes treatment in G309 field study

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics announced the completion of the treatment of all patients in its 'G309' exploratory field study to evaluate the efficacy and safety of Grass MATA MPL in subjects with seasonal allergic rhinitis or rhinoconjunctivitis, induced by grass pollen.

Read more
3 Mar 2021 19:14

TRADING UPDATES: Capita sells Irish unit; Daily Mail buys science mag

TRADING UPDATES: Capita sells Irish unit; Daily Mail buys science mag

Read more
3 Mar 2021 13:23

Allergy Therapeutics reports record pre-R&D operating profit

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics reported a 7% improvement in its revenue in actual terms in its interim results on Wednesday, and 5% growth at constant rate, to £54.0m.

Read more
13 Jan 2021 13:29

IN BRIEF: Allergy Therapeutics Hails Growth; Non-Exec Smith To Leave

IN BRIEF: Allergy Therapeutics Hails Growth; Non-Exec Smith To Leave

Read more
5 Jan 2021 18:01

IN BRIEF: Allergy Therapeutics And Imperial Start Peanut Allergy Study

IN BRIEF: Allergy Therapeutics And Imperial Start Peanut Allergy Study

Read more
5 Jan 2021 16:44

Allergy Therapeutics begins peanut allergy vaccine study

(Sharecast News) - Speciality allergy-focussed pharmaceutical company Allergy Therapeutics announced on Tuesday that an ex-vivo biomarker study of blood samples from peanut allergy patients had started at Imperial College London.

Read more
8 Dec 2020 21:07

IN BRIEF: Allergy Therapeutics Shareholders Revolt At General Meeting

IN BRIEF: Allergy Therapeutics Shareholders Revolt At General Meeting

Read more
20 Nov 2020 14:51

UK DIRECTOR DEALINGS SUMMARY: Landsec CEO Buys GBP300,000 Worth

UK DIRECTOR DEALINGS SUMMARY: Landsec CEO Buys GBP300,000 Worth

Read more
26 Oct 2020 14:17

IN BRIEF: Allergy Therapeutics Kicks Off Grass Allergy Therapy Study

IN BRIEF: Allergy Therapeutics Kicks Off Grass Allergy Therapy Study

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.